#AEMD

Last 24h 📈 Bullish 📈1

Last 7 Days 📈 Bullish 📈1

Last 30 Days 📈 Bullish 📈1

News 📈 Stocks

North Immunology to Go Public via $180M Reverse Merger with Aethlon Medical

September 18, 2026 (just now)

North Immunology secures $180 million and a Nasdaq listing via a reverse merger with Aethlon Medical to advance its dual-pathway inflammatory drug,…

NRTX AEMD KYMR +3

🌍 AMERICAS Read More →